Vir Biotechnology (VIR) Net Margin Growth (1y) (2019 - 2026)
Powered by 
Analysis
Vir Biotechnology (VIR) Net Margin Growth (1y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | -185.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -763.00 |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | 529.00 |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | 4,168.00 |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 673.00 |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | 2,208.00 |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | -392.00 |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | 29,636.00 |
| 10 | Vir Biotechnology | 1.92 Bn | 1.92 Bn | 238.95 Mn | 917,338.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 917,338.00 |
| Mar 31, 2026 | -42.94 Mn |
| Dec 31, 2025 | 77,824.00 |
| Sep 30, 2025 | -5.90 Mn |
| Jun 30, 2025 | -463,977.00 |
| Mar 31, 2025 | -387,382.00 |
| Dec 31, 2024 | -15,438.00 |
| Sep 30, 2024 | -278,747.00 |
| Jun 30, 2024 | 62,961.00 |
| Mar 31, 2024 | 10,802.00 |
| Dec 31, 2023 | -48,522.00 |
| Sep 30, 2023 | -623,904.00 |
| Jun 30, 2023 | -494,144.00 |
| Mar 31, 2023 | -26,588.00 |
| Dec 31, 2022 | -27,026.00 |
| Sep 30, 2022 | -5,977.00 |
| Jun 30, 2022 | -22,318.00 |
| Mar 31, 2022 | 859,021.00 |
| Dec 31, 2021 | 679,975.00 |
| Sep 30, 2021 | 449,501.00 |